What type of study is this?

December 8, 2025BloodOpen Access

Reduction of infections with intravenous immunoglobulin in chronic lymphocytic leukemia: A single-center retrospective analysis

View Full Paper

Ask AI

Bookmark

Authors

NSNirja Shah TPTulsi Patel TKThomas Kipps

Discussion

Member takes

Implication

Retrospective analysis finds intravenous immunoglobulin lowers infections in chronic lymphocytic leukemia, suggesting improved quality of life benefits.

Key Points

IVIG administration led to a 66% reduction in moderate or higher infections post-treatment.
Patients typically experienced fewer infections after starting IVIG, demonstrating significant clinical benefit.
This retrospective cohort analysis covers 79 chronic lymphocytic leukemia patients receiving IVIG.
Findings support the potential for IVIG to enhance patient quality of life by reducing infection rates.

Cite This Study

Shah et al. (2025) studied this question.

synapsesocial.com/papers/69362f694fa91c937236df14 https://doi.org/10.1182/blood-2025-4557

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis finds intravenous immunoglobulin lowers infections in chronic lymphocytic leukemia, suggesting improved quality of life benefits.